Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Alterations in the common fragile site gene Parkin in ovarian and other cancers.

Denison SR, Wang F, Becker NA, Schüle B, Kock N, Phillips LA, Klein C, Smith DI.

Oncogene. 2003 Nov 13;22(51):8370-8.

PMID:
14614460
2.

Parkin gene alterations in hepatocellular carcinoma.

Wang F, Denison S, Lai JP, Philips LA, Montoya D, Kock N, Schüle B, Klein C, Shridhar V, Roberts LR, Smith DI.

Genes Chromosomes Cancer. 2004 Jun;40(2):85-96.

PMID:
15101042
3.

Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.

Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, Croce CM.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):5956-61. Epub 2003 Apr 28.

4.

Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer.

Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI.

Genes Chromosomes Cancer. 2003 Sep;38(1):40-52.

PMID:
12874785
5.

Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.

Picchio MC, Martin ES, Cesari R, Calin GA, Yendamuri S, Kuroki T, Pentimalli F, Sarti M, Yoder K, Kaiser LR, Fishel R, Croce CM.

Clin Cancer Res. 2004 Apr 15;10(8):2720-4.

6.

A novel approach to simultaneously scan genes at fragile sites.

Willem P, Brown J, Schouten J.

BMC Cancer. 2006 Aug 8;6:205.

7.

Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.

Elfferich P, Verleun-Mooijman MC, Maat-Kievit JA, van de Warrenburg BP, Abdo WF, Eshuis SA, Leenders KL, Hovestadt A, Zijlmans JC, Stroy JP, van Swieten JC, Boon AJ, van Engelen K, Verschuuren-Bemelmans CC, Lesnik-Oberstein SA, Tassorelli C, Lopiano L, Bonifati V, Dooijes D, van Minkelen R.

Neurogenetics. 2011 Nov;12(4):263-71. doi: 10.1007/s10048-011-0302-9. Epub 2011 Oct 13.

8.

Common fragile sites, extremely large genes, neural development and cancer.

Smith DI, Zhu Y, McAvoy S, Kuhn R.

Cancer Lett. 2006 Jan 28;232(1):48-57. Epub 2005 Oct 10. Review.

PMID:
16221525
9.

Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.

Ishii H, Vecchione A, Furukawa Y, Sutheesophon K, Han SY, Druck T, Kuroki T, Trapasso F, Nishimura M, Saito Y, Ozawa K, Croce CM, Huebner K, Furukawa Y.

Mol Cancer Res. 2003 Nov;1(13):940-7.

10.
11.

WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM.

Cancer Res. 2000 Apr 15;60(8):2140-5.

12.

Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease.

Clarimon J, Johnson J, Dogu O, Horta W, Khan N, Lees AJ, Hardy J, Singleton A.

Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):120-3.

PMID:
15635662
13.

WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.

Yendamuri S, Kuroki T, Trapasso F, Henry AC, Dumon KR, Huebner K, Williams NN, Kaiser LR, Croce CM.

Cancer Res. 2003 Feb 15;63(4):878-81.

14.

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.

Letessier A, Garrido-Urbani S, Ginestier C, Fournier G, Esterni B, Monville F, Adélaïde J, Geneix J, Xerri L, Dubreuil P, Viens P, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Lopez M, Chaffanet M.

Oncogene. 2007 Jan 11;26(2):298-307. Epub 2006 Jul 3.

PMID:
16819513
15.

WWOX, the common chromosomal fragile site, FRA16D, cancer gene.

Ludes-Meyers JH, Bednarek AK, Popescu NC, Bedford M, Aldaz CM.

Cytogenet Genome Res. 2003;100(1-4):101-10.

16.

Alterations of common chromosome fragile sites in hematopoietic malignancies.

Ishii H, Furukawa Y.

Int J Hematol. 2004 Apr;79(3):238-42. Review.

PMID:
15168591
17.

WWOX, large common fragile site genes, and cancer.

Gao G, Smith DI.

Exp Biol Med (Maywood). 2015 Mar;240(3):285-95. doi: 10.1177/1535370214565992. Epub 2015 Jan 16. Review.

18.

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

Abbas N, Lücking CB, Ricard S, Dürr A, Bonifati V, De Michele G, Bouley S, Vaughan JR, Gasser T, Marconi R, Broussolle E, Brefel-Courbon C, Harhangi BS, Oostra BA, Fabrizio E, Böhme GA, Pradier L, Wood NW, Filla A, Meco G, Denefle P, Agid Y, Brice A.

Hum Mol Genet. 1999 Apr;8(4):567-74.

PMID:
10072423
19.

Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.

Michael D, Beer DG, Wilke CW, Miller DE, Glover TW.

Oncogene. 1997 Oct 2;15(14):1653-9.

20.

Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.

Yin DT, Wang L, Sun J, Yin F, Yan Q, Shen RL, Gao JX, He G.

Ann Clin Lab Sci. 2010 Summer;40(3):267-72.

PMID:
20689140

Supplemental Content

Support Center